What this means for you
- Good pricing copy should orient you without turning treatment into a checkout promise.
- The safest price page is clear about timing: personal payable amounts belong after the private steps that affect the pathway.
Questions to ask before you continue
- What does the public price include, and what can change later?
- Are medicine, labs, clinical services, courier, and support described separately where they need to be?
A public price should not behave like a cart
Price transparency helps people decide whether a pathway is worth starting. It becomes unsafe when a public price card starts acting like a medicine checkout.
Cendara can show programme starting prices for orientation, while keeping personal totals behind assessment, secure sign-in, care-option review, and required confirmations.
Programme pricing should explain what it includes
A real programme may include assessment processing, lifestyle support, care coordination, required lab handling, clinician review, portal support, and pharmacy or delivery coordination if approved.
That is different from listing dose, strength, or medicine price on a public page.
The payment boundary should be obvious
Payment can start service, lab, and review steps. It still should not promise approval, prescription, medicine availability, delivery, or results.
Clear pricing is not only about the Rand amount. It is also about saying what the amount cannot buy.
Questions people ask next
Is a public starting price my final total?
No. Public amounts are orientation. Personal payable amounts appear only after assessment, secure sign-in, care-option review, and required confirmations.
Why not just show a medicine price?
Because a responsible pathway may include assessment processing, support, lab coordination, clinician review, and pharmacy or delivery coordination if approved.
When to pause the online route
Pause if a price is presented as payment for a guaranteed outcome, medicine access, approval, or a clinical decision.